News MS Patients Can Use Smartphone to Take Part in Novartis Study of Movement Performance and Symptoms MS Patients Can Use Smartphone to Take Part in Novartis Study of Movement Performance and Symptoms by Patricia Inacio, PhD | August 24, 2017 Share this article: Share article via email Copy article link A multiple sclerosis study will collect information about patients’ movement performance and symptoms from their smartphones, NovartisĀ has reported. The studyĀ is aimed at evaluating in real time the daily challenges of people living with MS. The results may help researchers develop new ways to measure treatments’ effectiveness, the company said. The title of the study isĀ āEvaluation of Evidence from Smart Phone Sensors and Patient-Reported Outcomes in Participants with Multiple SclerosisĀ (elevateMS).ā Novartis is partnering withĀ Sage BionetworksĀ on what it has dubbed the elevateMS study.Ā TheĀ non-profit research organization is developing new predictors of disease to accelerate health research. A cellphone application will allow MS patients to send information about their situation from anywhere. The elevateMS app allows a smartphone user to register important features of their disease. It includes a symptom tracker tool that allows users to record their overall wellness. They can also get an overview of what’s been happening to them on an activity dashboard. The app will use sensors to gather information on their movements. It will also assess functional performance tasks that participants engage in. Patients can fill out questionnaires with the app as well. A division of Apple called the Apple ResearchKit platform developed the app. ThoseĀ interested in participating in the study can download itĀ here. Patients, neurologists and disease advocates gave Apple’s app team input that helped with the design. “As physicians, we always want to know how our patients with MS are doing on the treatments we prescribe,” Dr. Stanley Cohan, medical director of the Providence Multiple Sclerosis Center in Portland, Oregon, said in a press release. “With the elevateMS app, study participants can frequently document their symptoms in a personal health story,” saidĀ Cohan, one of the scientific advisors to the study. “In turn, this data may provide researchers with new ways to look at disease progression and treatment effectiveness.” The elevateMS study is open to MS patients 18 years old or older in the United States who own a smartphone. Additional information about it is available atĀ www.elevatems.org. Print This Page About the Author Patricia Inacio, PhD Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship. Tags app, Novartis, smartphone
April 24, 2024 News by Lindsey Shapiro, PhD Autoantibodies seen in blood years before MS diagnosis: Study
April 23, 2024 News by Mary Chapman Itās year 10 for MSAAās upcoming Improving Lives Benefit for MS
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year